BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26307193)

  • 1. Discovery of a new method for potent drug development using power function of stoichiometry of homomeric biocomplexes or biological nanomotors.
    Pi F; Vieweger M; Zhao Z; Wang S; Guo P
    Expert Opin Drug Deliv; 2016; 13(1):23-36. PubMed ID: 26307193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approach to develop ultra-high inhibitory drug using the power function of the stoichiometry of the targeted nanomachine or biocomplex.
    Shu D; Pi F; Wang C; Zhang P; Guo P
    Nanomedicine (Lond); 2015 Jul; 10(12):1881-97. PubMed ID: 26139124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Potent Antiviral Drugs Inspired by Viral Hexameric DNA-Packaging Motors with Revolving Mechanism.
    Pi F; Zhao Z; Chelikani V; Yoder K; Kvaratskhelia M; Guo P
    J Virol; 2016 Sep; 90(18):8036-46. PubMed ID: 27356896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of Asymmetrical Hexameric Biomimetic Motors with Continuous Single-Directional Motion by Sequential Coordination.
    Zhao Z; Zhang H; Shu D; Montemagno C; Ding B; Li J; Guo P
    Small; 2017 Jan; 13(1):. PubMed ID: 27709780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binomial distribution for quantification of protein subunits in biological nanoassemblies and functional nanomachines.
    Fang H; Zhang P; Huang LP; Zhao Z; Pi F; Montemagno C; Guo P
    Nanomedicine; 2014 Oct; 10(7):1433-40. PubMed ID: 24650885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revolving hexameric ATPases as asymmetric motors to translocate double-stranded DNA genome along one strand.
    Bohmer M; Bhullar AS; Weitao T; Zhang L; Lee JH; Guo P
    iScience; 2023 Jun; 26(6):106922. PubMed ID: 37305704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction to biological complexity as a missing link in drug discovery.
    Gintant GA; George CH
    Expert Opin Drug Discov; 2018 Aug; 13(8):753-763. PubMed ID: 29871539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using label-free screening technology to improve efficiency in drug discovery.
    Halai R; Cooper MA
    Expert Opin Drug Discov; 2012 Feb; 7(2):123-31. PubMed ID: 22468914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles and applications of Raman spectroscopy in pharmaceutical drug discovery and development.
    Gala U; Chauhan H
    Expert Opin Drug Discov; 2015 Feb; 10(2):187-206. PubMed ID: 25399993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and optimization of peptide macrocycles.
    White AM; Craik DJ
    Expert Opin Drug Discov; 2016 Dec; 11(12):1151-1163. PubMed ID: 27718641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Providing data science support for systems pharmacology and its implications to drug discovery.
    Hart T; Xie L
    Expert Opin Drug Discov; 2016; 11(3):241-56. PubMed ID: 26689499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two classes of nucleic acid translocation motors: rotation and revolution without rotation.
    Guo P; Grainge I; Zhao Z; Vieweger M
    Cell Biosci; 2014; 4(1):54. PubMed ID: 25276341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular topology as a novel approach for drug discovery.
    Gálvez J; Gálvez-Llompart M; García-Domenech R
    Expert Opin Drug Discov; 2012 Feb; 7(2):133-53. PubMed ID: 22468915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of assay technology as applied to safety assessment in reducing compound attrition in drug discovery.
    Thomas CE; Will Y
    Expert Opin Drug Discov; 2012 Feb; 7(2):109-22. PubMed ID: 22468913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of drug discovery: enabling technologies for enhancing lead characterization and profiling therapeutic potential.
    Janero DR
    Expert Opin Drug Discov; 2014 Aug; 9(8):847-58. PubMed ID: 24965547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilized helical peptides: overview of the technologies and its impact on drug discovery.
    Klein M
    Expert Opin Drug Discov; 2017 Nov; 12(11):1117-1125. PubMed ID: 28889766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applied metabolomics in drug discovery.
    Cuperlovic-Culf M; Culf AS
    Expert Opin Drug Discov; 2016 Aug; 11(8):759-70. PubMed ID: 27366968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological Nanomotors with a Revolution, Linear, or Rotation Motion Mechanism.
    Guo P; Noji H; Yengo CM; Zhao Z; Grainge I
    Microbiol Mol Biol Rev; 2016 Mar; 80(1):161-86. PubMed ID: 26819321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France.
    Napper AD
    IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316
    [No Abstract]   [Full Text] [Related]  

  • 20. Multitarget ligands in antibacterial research: progress and opportunities.
    East SP; Silver LL
    Expert Opin Drug Discov; 2013 Feb; 8(2):143-56. PubMed ID: 23252414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.